Williams & Novak »

Taysha Gene Therapies shares owned by Williams & Novak

Quarter-by-quarter ownership of Taysha Gene Therapies (TSHA) shares owned by Williams & Novak from 13F filings

Historical chart of Williams & Novak investment in Taysha Gene Therapies

Tip: Access up to 7 years of quarterly data

All positions including Taysha Gene Therapies held by Williams & Novak consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Taysha Gene Therapies by Williams & Novak

Quarter filed Position value Share count Share price at filing
2024-12-31 $78k 45k 1.73
2024-09-30 $91k 45k 2.01
2024-06-30 $101k 45k 2.24
2024-03-31 $80k 45k 1.77
2023-12-31 $80k 45k 1.77

More positions owned by Williams & Novak

Fidelity Merrimack Str Tr Total Bd Etf (FBND)
Pimco Equity Ser Rafi Dyn Ml Us (MFUS)
Fidelity Covington Trust Enhanced Large (FELC)
Sypris Solutions (SYPR)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Apple (AAPL)
Ishares Tr Calif Mun Bd Etf (CMF)
Ishares Tr Core Msci Total (IXUS)
Ishares Silver Tr Ishares (SLV)
Pimco Equity Ser Rafi Dyn Emerg (MFEM)
Ishares Tr Core Div Grwth (DGRO)
Pimco CA Municipal Income Fund (PCQ)
Ishares Tr Core Msci Eafe (IEFA)
Pimco Etf Tr Multisector Bd (PYLD)
Ishares Tr International Sl (ISCF)

View all positions for Williams & Novak

Top funds holding Taysha Gene Therapies

venBio Select Advisor
Morgan Stanley
FMR
BlackRock
RA Capital Management
Octagon Capital Advisors
Vanguard Group
Rtw Investments
Siren
State Street Corporation
Adage Capital Partners GP
Baker Bros. Advisors
Tybourne Capital Management
Geode Capital Management
VR Adviser

View all funds holding Taysha Gene Therapies